Cello Health (CLL)

Sector:

Health Care

Index:

FTSE AIM All-Share

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

127.00p
   
  • Change Today:
    -1.50p
  • 52 Week High: 139.50p
  • 52 Week Low: 96.00p
  • Currency: UK Pounds
  • Shares Issued: 104.77m
  • Volume: 89,452
  • Market Cap: 133.06m
  • RiskGrade: 118

Financial Analysis

Select chart: EPS | Dividend | Revenue

Key Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-14 169.87 3.79 8.14p 11.3 0.9 +12% 2.60p 2.8%
31-Dec-15 156.74 5.03 8.72p 10.1 1.4 +7% 2.86p 3.2%
31-Dec-16 165.27 (1.69) 8.66p 11.9 n/a -1% 3.40p 3.3%
31-Dec-17 170.29 5.82 7.93p 16.9 n/a -8% 3.50p 2.6%
31-Dec-18 165.57 8.42 9.02p 12.3 0.9 +14% 3.80p 3.4%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 170.95 12.90 9.20p 13.8 6.9 +2% 4.00p 3.1%
31-Dec-20 178.15 13.80 9.80p 13.0 2.0 +6% 4.15p 3.2%

Copyright © 2019 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest 11.30 10.09 12.50 1.13

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Cello Health Market Data

Currency UK Pounds
Share Price 127.00p
Change Today -1.50p
% Change -1.17 %
52 Week High 139.50p
52 Week Low 96.00p
Volume 89,452
Shares Issued 104.77m
Market Cap 133.06m
RiskGrade 118

Cello Health Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
76.95% below the market average76.95% below the market average76.95% below the market average76.95% below the market average76.95% below the market average
35.29% above the sector average35.29% above the sector average35.29% above the sector average35.29% above the sector average35.29% above the sector average
Price Trend
56.60% above the market average56.60% above the market average56.60% above the market average56.60% above the market average56.60% above the market average
69.23% above the sector average69.23% above the sector average69.23% above the sector average69.23% above the sector average69.23% above the sector average
Income
1.07% below the market average1.07% below the market average1.07% below the market average1.07% below the market average1.07% below the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average
Growth
31.9% below the market average31.9% below the market average31.9% below the market average31.9% below the market average31.9% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Cello Health Dividends

  Latest Previous
  Final Interim
Ex-Div 25-Apr-19 04-Oct-18
Paid 24-May-19 02-Nov-18
Amount 2.75p 1.10p

Trades for 21-Aug-2019

Time Volume / Share Price
16:09 1,000 @ 128.50p
14:43 31,130 @ 128.00p
14:41 787 @ 128.00p
13:06 150 @ 128.00p
11:54 3,040 @ 128.00p

Cello Health Key Personnel

CEO Mark Scott

Top of Page